Skip to main content
Carl Blau, MD, Oncology, Seattle, WA, Seattle Children's Hospital

CarlAnthonyBlauMD

Oncology Seattle, WA

Professor, Medicine, University of Washington School of Medicine

Dr. Blau is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Blau's full profile

Already have an account?

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 1989 - 1992
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1986 - 1989
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 1986

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1989 - 2024
  • American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • A Multi-Omic Precision Medicine Clinical Trial in Acute Leukemia
    Carl Anthony Blau, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • High Throughput Drug Screening of Leukemia Stem Cells Reveals Resistance to Standard Therapies and Sensitivity to Other Agents in Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Grant Support

  • Modeling Mammalian GenomesNational Institute Of General Medical Sciences2011–2012
  • Erythropoietin Blockade For The Treatment Of CancerNational Cancer Institute2008–2011
  • Self Renewal And Differentiation Of Embryonic Stem CellsNational Institute Of General Medical Sciences2007–2011
  • Regulation Of Human Embryonic Stem Cell Self-RenewalNational Institute Of General Medical Sciences2007–2011
  • Cell Biosystems Firefly 3000 SystemNational Center For Research Resources2010
  • Receptor Specifcity In The Proliferation And Differentiation Of Stem CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2009
  • Receptor Specificity In The Proliferation And Differentiation Of Stem CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2008
  • Safety Of Chemical Inducers Of Dimmerization And Expanding GM Erythroid CellsNational Heart, Lung, And Blood Institute2004–2008
  • Administrative CoreNational Institute Of General Medical Sciences2007
  • Uw/Fhcrc Exploratory Center For Human ES Cell ResearchNational Institute Of General Medical Sciences2003–2006
  • Hemopoietic Stem Cell PlasticityNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2004
  • Proliferative Switch For Genetically Modified CellsNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2004
  • Proliferation % Differentiation Of Hemopoietic Stem CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2002
  • Core--ClinicalNational Heart, Lung, And Blood Institute2000–2002
  • Mixed Chimerism In The HemoglobinopathiesNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2002
  • Stem Cell Expansion Using Chemical Inducers Of Dimerization (CID)National Heart, Lung, And Blood Institute1999–2002
  • Effects Of Hydroxyurea In Sickle Cell DiseaseNational Center For Research Resources2000
  • Effects Of Hydroxyurea On Circulating Progenitors In Sickle Cell DiseaseNational Center For Research Resources1998–2000
  • Butyrate Response Elements Within The Beta-Globin LocusNational Institute Of Diabetes And Digestive And Kidney Diseases1994
  • Butyrate Response Elements Within The Beta Globin LocusNational Institute Of Diabetes And Digestive And Kidney Diseases1992

Hospital Affiliations